Colorado’s IMMUNOe International Research Centers to Participate in Novartis AG Clinical Research Trial Evaluating the Use of Investigational Pandemic Flu Vaccine in Children

DENVER--(BUSINESS WIRE)--IMMUNOe International Research Centers: A local physician is working with parents of children between 3 and 8 years of age in the region as part of an important clinical research trial that will be necessary to ensure that a vaccine against the new A/H1N1 virus is available in the U.S. this Fall/Winter. The doctor is available to speak about the clinical research trial and why it is of importance to children in the area.
MORE ON THIS TOPIC